The only indirect evidence for NF-κB-mediated DMT1 regulation in brain ischemia comes from a study showing that tanshinone IIA, a natural compound reported to inhibit NF-κB activity [40], can downregulate DMT1 expression, iron elevation and brain infarct volume in mice exposed to MCAO [13]. This evidence concerns the gene SLC11A2 and brain ischemia.